DLH to Expand Digital Transformation Services at the National Heart, Lung, and Blood Institute
August 02 2023 - 8:00AM
DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the
“Company”), a leading provider of digital transformation,
systems engineering and integration, and science research and
development solutions to federal agencies, today announced that it
has been awarded a contract to provide agile development, data
sciences, and health IT services for the National Institutes of
Health’s (“NIH”) National Heart, Lung, and Blood Institute
(“NHLBI”). NHLBI is an institute dedicated to providing global
leadership for a research, training, and education program to
promote the prevention and treatment of heart, lung, blood, and
sleep disorders.
This new contract is a Blanket Purchase Agreement (“BPA”) issued
against the General Services Administration Multiple Award Schedule
that includes a period of performance of five years. Including DLH,
there are five awardees on the contract, and the government
estimates that the aggregate ceiling for this BPA will total $85
million. Specific values will be allocated to contractors as task
orders are competed and awarded. Through this award, the Company
will modernize and optimize the NHLBI Information Technology and
Applications Center’s (“ITAC”) software and application portfolio,
helping the institute embrace new technologies and methods while
increasing alignment with mission needs. Services to be provided
include systems and software development, integration, testing, and
operations; big data management and analytics; bioinformatics and
data science support; cybersecurity; and strategic advisory
services. The work anticipated under this contract is key to
NHLBI’s digital transformation and modernization strategy,
emphasizing the implementation and adoption of low-code / no-code
platforms as well as Zero-Trust Architecture alignment for the
enterprise.
"We are proud that NHLBI continues to trust DLH for their
complex IT and scientific support services, and are thrilled about
this opportunity to expand our support of the Institute’s mission
in partnership with ITAC,” said Diane Yarnell, President of DLH’s
Health IT Business Unit. “DLH leveraged the capabilities and
expertise of multiple operating units in winning this award,
demonstrating the value creation our unified enterprise is capable
of.”
“This award provides yet another contract vehicle through which
DLH will utilize its digital transformation, systems engineering,
and cybersecurity expertise in support of a customer’s critical
public health mission,” said Zach Parker, DLH President and CEO.
“With an intimate understanding of NHLBI’s scientific and
information technology needs, and a suite of advanced solutions and
technological capabilities, DLH is perfectly positioned to deliver
the support that our customer requires to retain its position as a
global leader in heart, lung, and blood research, training, and
education.”
About DLH
DLH (NASDAQ:DLHC) delivers improved health and national security
readiness solutions for federal programs through science research
and development, systems engineering and integration, and digital
transformation. The Company’s experts in public health, performance
evaluation, and health operations solve the complex problems faced
by civilian and military customers alike, leveraging digital
transformation, artificial intelligence, advanced analytics,
cloud-based applications, telehealth systems, and more. With over
3,200 employees dedicated to the idea that “Your Mission is Our
Passion,” DLH brings a unique combination of government sector
experience, proven methodology, and unwavering commitment to
innovation to improve the lives of millions. For more information,
visit www.DLHcorp.com.
Safe Harbor Statement under the Private Securities
Litigation Reform Act of 1995:
This press release may contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements relate to future events or DLH’s future
financial performance. Any statements that refer to expectations,
projections or other characterizations of future events or
circumstances or that are not statements of historical fact
(including without limitation statements to the effect that the
Company or its management “believes”, “expects”, “anticipates”,
“plans”, “intends” and similar expressions) should be considered
forward-looking statements that involve risks and uncertainties
which could cause actual events or DLH’s actual results to differ
materially from those indicated by the forward-looking statements.
Forward-looking statements in this release include, among others,
statements regarding estimates of future revenues. These statements
reflect our belief and assumptions as to future events that may not
prove to be accurate. Our actual results may differ materially from
such forward-looking statements made in this release due to a
variety of factors, including: the outbreak of the novel
coronavirus (“COVID-19”), including the measures to reduce its
spread, and its impact on the economy and demand for our services,
are uncertain, cannot be predicted, and may precipitate or
exacerbate other risks and uncertainties; the risk that we will not
realize the anticipated benefits of the GRSi acquisition;
(including anticipated future financial operating performance and
results); diversion of management’s attention from normal daily
operations of the business and the challenges of managing larger
and more widespread operations resulting from the acquisition; the
inability to retain GRSi employees and customers; contract awards
in connection with re-competes for present business and/or
competition for new business; the risks and uncertainties
associated with client interest in and purchases of new services;
compliance with new bank financial and other covenants; changes in
client budgetary priorities; government contract procurement (such
as bid and award protests, small business set asides, loss of work
due to organizational conflicts of interest, etc.) and termination
risks; the ability to successfully integrate the operations of GRSi
and any future acquisitions; the impact of inflation and higher
interest rates; and other risks described in our SEC filings. For a
discussion of such risks and uncertainties which could cause actual
results to differ from those contained in the forward-looking
statements, see “Risk Factors” in the Company’s periodic reports
filed with the SEC, including our Annual Report on Form 10-K for
the fiscal year ended September 30, 2022, as well as subsequent
reports filed thereafter. The forward-looking statements contained
herein are not historical facts, but rather are based on current
expectations, estimates, assumptions and projections about our
industry and business.
Such forward-looking statements are made as of the date hereof
and may become outdated over time. The Company does not assume any
responsibility for updating forward-looking statements, except as
may be required by law.
CONTACTS:
MEDIA
Email: dlh.communications@dlhcorp.com
INVESTOR RELATIONS
Contact: Chris Witty
Phone: 646-438-9385
Email: cwitty@darrowir.com
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Apr 2024 to May 2024
DLH (NASDAQ:DLHC)
Historical Stock Chart
From May 2023 to May 2024